(CNSNews.com) – The Drug Enforcement Agency (DEA) has declined two petitions to reclassify marijuana from a Schedule I controlled substance under the Controlled Substances Act (CSA), noting that cannabis "does not have a currently accepted medical use."
"Using established scientific standards that are consistent with that same FDA drug approval process and based on the FDA's [Food and Drug Administration] scientific and medical evaluation, as well as the legal standards in the CSA, marijuana will remain a schedule I controlled substance," Chuck Rosenberg, DEA's acting administrator, said in his August 11 letter to petitioners.
STATE HOUSE — Robert Cordy, whose last day as a member of the Supreme Judicial Court was Friday, will return to his former law firm, McDermott, Will & Emery, in October.
After 15-plus years on the bench, Cordy plans to practice the same type of civil and criminal litigation that comprised his portfolio earlier, along with "corporate problem-solving," which he said is a "love" of his.
